Entyvio (Generic Vedolizumab): Complete Medication Guide
Key Takeaways
Vedolizumab is a biologic medication that treats inflammatory bowel diseases like Crohn's disease and ulcerative colitis.
It works by targeting immune cells in the gut to reduce inflammation and help the intestines heal.
The generic version offers the same effectiveness as the brand-name Entyvio at a lower cost.
Common side effects include headache, fatigue, and nausea; serious side effects are rare but require immediate attention.
Treatment typically involves intravenous infusions every 4-8 weeks after an initial loading phase.
Entyvio (Generic Vedolizumab) Overview
Vedolizumab is a biologic medication that belongs to a class of drugs called integrin receptor antagonists. It's used to treat two serious inflammatory bowel diseases: Crohn's disease and ulcerative colitis. These conditions cause the immune system to attack the digestive tract, leading to chronic inflammation, pain, and other complications.
Vedolizumab works by blocking specific immune cells that cause inflammation in the gut. It prevents these cells from reaching the intestines and causing damage. By targeting inflammation at its source, vedolizumab helps reduce symptoms like diarrhea, abdominal pain, and bleeding. The generic version offers the same active ingredient as brand-name Entyvio, making it an affordable option for people who need long-term treatment.
This medication is typically prescribed when other treatments haven't worked well enough. It's given through intravenous infusions at a healthcare facility, which allows doctors to monitor you during treatment. Many patients see improvement in their symptoms within a few weeks of starting vedolizumab, though full benefits may take longer to appear.
Side Effects
Most people tolerate vedolizumab well, though side effects are possible. Understanding what to expect helps you recognize when to contact your healthcare provider.
Common Side Effects
Headache — One of the most frequently reported side effects; usually mild to moderate and manageable with rest or over-the-counter pain relief.
Fatigue — Feeling unusually tired or lacking energy is common, especially during the initial weeks of treatment.
Nausea — Mild stomach upset or queasiness may occur but typically improves with time.
Joint or muscle pain — Some patients experience aches in their joints or muscles, similar to what you might feel with mild arthritis.
Fever — A low-grade fever may develop after an infusion but usually resolves within a day or two.
Upper respiratory infection symptoms — Sore throat, cough, or nasal congestion may occur as the immune system adjusts.
Serious Side Effects
Severe allergic reactions — Anaphylaxis is rare but serious; symptoms include difficulty breathing, chest pain, or swelling of the face and throat during or shortly after infusion.
Progressive multifocal leukoencephalopathy (PML) — This is an extremely rare brain infection caused by a virus; watch for confusion, memory problems, or changes in vision.
Serious infections — Because vedolizumab affects immune function, infections like tuberculosis or fungal infections may occur; seek help if you develop persistent fever or unusual symptoms.
Liver problems — Rarely, the medication may cause liver inflammation; signs include yellowing of the skin or eyes, dark urine, or abdominal pain.
When to Seek Medical Attention
Contact your healthcare provider right away if you experience chest pain, difficulty breathing, severe swelling, or signs of infection like high fever and chills. These symptoms may indicate a serious reaction that requires immediate evaluation. Additionally, if you notice confusion, memory loss, weakness on one side of your body, or vision changes, seek emergency care—these could signal a rare but serious complication.
During your infusions, medical staff monitor you closely for reactions. Report any unusual symptoms to your healthcare team, even if they seem minor. Some side effects like fatigue or mild headache may improve as your body adjusts to the medication.
Dosage
Dose Level or Form |
Dose |
Key Detail |
Loading Phase (Weeks 0, 2, 6) |
300 mg IV infusion |
Given at weeks 0, 2, and 6; each infusion takes about 30 minutes |
Maintenance Phase (8 weeks) |
300 mg IV infusion |
Given every 8 weeks after loading phase completes |
Maintenance Phase (4 weeks) |
300 mg IV infusion |
Some patients benefit from dosing every 4 weeks instead of 8 weeks |
Pediatric Patients |
Weight-based dosing |
Children receive doses calculated based on body weight; typically lower than adult doses |
Drug Interactions
Vedolizumab can interact with certain medications and substances. It's important to tell your healthcare provider about everything you're taking, including over-the-counter drugs, supplements, and herbal products.
Live Vaccines
Live vaccines like MMR or varicella should not be given while taking vedolizumab, as the medication weakens immune response and may reduce vaccine effectiveness. Discuss vaccination timing with your doctor before starting treatment.
TNF Inhibitors (Infliximab, Adalimumab, Etanercept)
Combining vedolizumab with TNF inhibitors significantly increases infection risk without providing additional benefit. These medications work similarly and are not typically used together.
Immunosuppressants (Azathioprine, Mercaptopurine)
Using vedolizumab alongside other immune-suppressing drugs raises the risk of serious infections. Your doctor may adjust dosing or choose alternative treatments if both are needed.
Corticosteroids (Prednisone, Methylprednisolone)
While corticosteroids are sometimes used with vedolizumab during flare-ups, prolonged combined use increases infection risk. Work closely with your doctor to minimize corticosteroid doses.
Biologics for Other Conditions
Other biologic medications for rheumatoid arthritis or psoriasis should not be combined with vedolizumab due to compounded immune suppression. Tell your doctor about all biologics you take or have taken recently.
NSAIDs (Ibuprofen, Naproxen)
NSAIDs may reduce vedolizumab's effectiveness and can worsen inflammatory bowel disease symptoms. Acetaminophen is usually a safer pain relief option while on this medication.
Continue Learning
Related articles you might find helpful
Pros and Cons
Pros
Effective for moderate-to-severe IBD — Vedolizumab provides meaningful improvement in symptoms and inflammation for many patients who haven't responded to other treatments.
Targeted mechanism of action — By working specifically in the gut, it may cause fewer system-wide side effects than older medications.
Cost-effective compared to brand-name — Generic vedolizumab costs significantly less than Entyvio while offering identical benefits.
Convenient dosing schedule — Once stable, most patients receive infusions every 8 weeks, reducing treatment burden compared to daily pills.
Allows dose reduction of other medications — Many patients can lower corticosteroid doses after vedolizumab starts working, reducing long-term side effects.
Cons
Requires regular infusions — You must visit a healthcare facility for intravenous infusions, which isn't convenient for everyone.
Increased infection risk — The immune-suppressing effects mean you're more vulnerable to infections, some of which could be serious.
Slow onset — It may take several weeks or months to notice improvement, requiring patience during the loading phase.
Cost and insurance barriers — Even generic vedolizumab is expensive; some insurance plans require prior authorization or have high copays.
Rare but serious complications — Though uncommon, PML and other severe infections are possible risks that require ongoing monitoring.
Frequently Asked Questions
Get answers to common questions about vedolizumab.
Most patients begin noticing symptom improvement within 2-4 weeks of starting treatment, though some take longer. Full benefits typically develop over 8-12 weeks as the medication builds up in your system. The loading phase (three infusions over six weeks) helps establish adequate medication levels. If you don't see improvement after three months, talk to your doctor about adjusting your dose or exploring other options.
No, you should not stop vedolizumab without your doctor's approval, even if your symptoms improve significantly. Stopping suddenly may cause inflammation to return and symptoms to flare up. Your healthcare provider will help determine if and when you might gradually reduce or discontinue treatment. Some patients require long-term maintenance therapy to keep their disease under control.
Yes, generic vedolizumab contains the exact same active ingredient and works identically to brand-name Entyvio. Generic and brand-name drugs are equally effective because they meet the same FDA standards for safety and efficacy. The primary difference is cost—generic versions are significantly cheaper, making treatment more affordable for patients and families.
Contact your healthcare provider right away to reschedule your missed infusion. Missing doses can allow inflammation to return and reduce the medication's effectiveness. Your doctor will advise you on when to come back for your next dose. Consistency with your infusion schedule is important for maintaining control of your inflammatory bowel disease.
Vedolizumab can be used with some other IBD medications like mesalamine, but should not be combined with TNF inhibitors or other biologic medications due to increased infection risk. Corticosteroids may be used temporarily during flare-ups. Your healthcare provider will review all your current medications and determine the safest combination for your specific situation.
The Bottom Line
Vedolizumab is a powerful biologic medication that helps many people with moderate-to-severe Crohn's disease and ulcerative colitis achieve better control of their symptoms and reduce intestinal inflammation. The generic version provides the same proven benefits as brand-name Entyvio at a significantly lower cost. Like all medications, vedolizumab carries potential side effects and risks—particularly increased infection vulnerability—but for the right patients, the benefits often outweigh these concerns. Treatment requires regular infusions at a healthcare facility and close monitoring by your medical team. If you're struggling with inflammatory bowel disease symptoms despite other treatments, vedolizumab may be worth discussing with your gastroenterologist. Doctronic can help you understand your options and connect with healthcare professionals who can provide personalized guidance. Ready to take control of your health? Get started with Doctronic today.
